Development and validation of a diverticular clinical score for symptomatic uncomplicated diverticular disease after acute diverticulitis in a prospective patient cohort

被引:6
|
作者
Lahat, Adi [1 ]
Fidder, Herma H. [2 ]
Ben-Horin, Shomron [3 ]
机构
[1] Tel Aviv Univ, Sackler Sch Med, Sheba Med Ctr, Dept Gastroenterol, IL-52621 Tel Aviv, Israel
[2] Univ Med Ctr Utrecht, Dept Gastroenterol & Hepatol, Utrecht, Netherlands
[3] Sackler Sch Med, Sheba Med Ctr, Dept Gastroenterol, Tel Aviv, Israel
关键词
acute diverticulitis; clinical score; diverticular disease; symptomatic uncomplicated diverticular disease; QUALITY-OF-LIFE; HEALTH SURVEY SF-36; COMPLICATED DIVERTICULITIS; DOUBLE-BLIND; MESALAZINE; COLON; MANAGEMENT; TRIAL; INDEX; RECURRENCE;
D O I
10.1177/1756284820913210
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background: Following an attack of acute diverticulitis (AD), many patients continue to suffer from a complex of symptoms, titled 'symptomatic uncomplicated diverticular disease (SUDD)'. To date, there is no validated clinical score for standardized assessment of patients with SUDD, thereby hampering the interpretation of observational studies and the conductance of clinical trials. We aimed to develop a validated SUDD clinical score. Methods: Data from previous prospective study of patients after AD was used to devise the score's first version. Validation was first performed using a focus group of patients after AD SUDD who underwent a structured cognitive personal interview. Thereafter, the diverticular clinical score (DICS) was applied for a second validation cohort. DICS scores of validation cohort were compared with physicians' global assessment for disease severity and inflammatory markers. Results: In DICS second validation using 48 patients prospectively recruited after AD SUDD, a correlation matrix demonstrated strong correlation between total questionnaire's score and the presence of elevated inflammatory markers (rho = 0.84). Mean score in patients with elevated inflammatory markers compared with those without inflammation was 17.8 versus 6.2, respectively, p < 0.001. Cronbach's alpha for measuring internal consistency was 0.91. DICS discriminated accurately between patients with/without active disease, as gauged by the physicians global assessment (area under the curve receiver operating characteristic = 0.989). Conclusions: Patients suffering from post-AD SUDD exhibit a wide range of symptoms. The newly developed DICS accurately and reproducibly quantitates SUDD-related symptom severity. The DICS may prove useful for monitoring SUDD in clinical practice and in research settings, as well as facilitating patient stratification and therapeutic decisions.
引用
收藏
页数:11
相关论文
共 50 条
  • [21] Effect of mesalazine on recurrence of diverticulitis in patients with symptomatic uncomplicated diverticular disease: a meta-analysis with trial sequential analysis of randomised controlled trials
    Hajibandeh, S.
    Khan, R. Muhammad Asaf
    Mohammed, S.
    BRITISH JOURNAL OF SURGERY, 2018, 105 : 178 - 178
  • [22] Role of acute diverticulitis in the development of complicated colonic diverticular disease and 1-year mortality after diagnosis in the UK: population-based cohort study
    Humes, David J.
    West, Joe
    GUT, 2012, 61 (01) : 95 - 100
  • [23] Effect of mesalazine on recurrence of diverticulitis in patients with symptomatic uncomplicated diverticular disease: a meta-analysis with trial sequential analysis of randomized controlled trials
    Khan, R. M. A.
    Ali, B.
    Hajibandeh, S.
    Hajibandeh, S.
    COLORECTAL DISEASE, 2018, 20 (06) : 469 - 478
  • [24] Clinical and symptom scores are significantly correlated with fecal microbiota features in patients with symptomatic uncomplicated diverticular disease: a pilot study
    Kvasnovsky, Charlotte L.
    Leong, Lex E. X.
    Choo, Jocelyn M.
    Abell, Guy C. J.
    Papagrigoriadis, Savvas
    Bruce, Kenneth D.
    Rogers, Geraint B.
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2018, 30 (01) : 107 - 112
  • [25] Cyclic rifaximin therapy effectively prevents the recurrence of symptoms after exacerbation of symptomatic uncomplicated diverticular disease: a retrospective study
    Pietrzak, Anna M.
    Dziki, Adam
    Banasiewicz, Tomasz
    Regula, Jaroslaw
    GASTROENTEROLOGY REVIEW-PRZEGLAD GASTROENTEROLOGICZNY, 2019, 14 (01): : 69 - 78
  • [26] Eubiotic effect of rifaximin is associated with decreasing abdominal pain in symptomatic uncomplicated diverticular disease: results from an observational cohort study
    Vladimir Ivashkin
    Oleg Shifrin
    Roman Maslennikov
    Elena Poluektova
    Alexander Korolev
    Anna Kudryavtseva
    George Krasnov
    Nona Benuni
    Giovanni Barbara
    BMC Gastroenterology, 23
  • [27] Mesalazine and/or Lactobacillus casei in preventing recurrence of symptomatic uncomplicated diverticular disease of the colon -: A prospective, randomized, open-label study
    Tursi, A
    Brandimarte, G
    Giorgetti, GM
    Elisei, W
    JOURNAL OF CLINICAL GASTROENTEROLOGY, 2006, 40 (04) : 312 - 316
  • [28] Eubiotic effect of rifaximin is associated with decreasing abdominal pain in symptomatic uncomplicated diverticular disease: results from an observational cohort study
    Ivashkin, Vladimir
    Shifrin, Oleg
    Maslennikov, Roman
    Poluektova, Elena
    Korolev, Alexander
    Kudryavtseva, Anna
    Krasnov, George
    Benuni, Nona
    Barbara, Giovanni
    BMC GASTROENTEROLOGY, 2023, 23 (01)
  • [29] Prognostic performance of the 'DICA' endoscopic classification and the 'CODA' score in predicting clinical outcomes of diverticular disease: an international, multicentre, prospective cohort study
    Tursi, Antonio
    Brandimarte, Giovanni
    Di Mario, Francesco
    Elisei, Walter
    Picchio, Marcello
    Allegretta, Leonardo
    Annunziata, Maria Laura
    Bafutto, Mauro
    Bassotti, Gabrio
    Bianco, Maria Antonietta
    Colucci, Raffaele
    Conigliaro, Rita
    Dumitrascu, Dan
    Escalante, Ricardo
    Ferrini, Luciano
    Forti, Giacomo
    Franceschi, Marilisa
    Graziani, Maria Giovanna
    Lammert, Frank
    Latella, Giovanni
    Maconi, Giovanni
    Nardone, Gerardo
    de Castro Oliveira, Lucia Camara
    Oliveira, Enio Chaves
    Papa, Alfredo
    Papagrigoriadis, Savvas
    Pietrzak, Anna
    Pontone, Stefano
    Poskus, Tomas
    Pranzo, Giuseppe
    Reichert, Matthias Christian
    Rodino, Stefano
    Regula, Jaroslaw
    Scaccianoce, Giuseppe
    Scaldaferri, Franco
    Vassallo, Roberto
    Zampaletta, Costantino
    Zullo, Angelo
    Piovani, Daniele
    Bonovas, Stefanos
    Danese, Silvio
    GUT, 2022, 71 (07) : 1350 - 1358
  • [30] One-year cyclic therapy with rifaximin-α is effective in the treatment of SUDD (Symptomatic Uncomplicated Diverticular Disease) also in patients with a history of complicated diverticulitis
    Pietrzak, Anna
    Rydzewska, Grazyna
    Neubauer, Katarzyna
    Banasiewicz, Tomasz
    Tarnowski, Wieslaw
    POLISH JOURNAL OF SURGERY, 2023, 95 (04) : 54 - 60